Man Group plc - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Man Group plc ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$246,000
-94.7%
43,000
-86.4%
0.00%
-95.7%
Q2 2020$4,636,000
+20.8%
315,161
+93.0%
0.02%
+76.9%
Q4 2019$3,839,000
+610.9%
163,328
+462.5%
0.01%
+550.0%
Q2 2019$540,000
-49.8%
29,036
-34.1%
0.00%
-50.0%
Q1 2019$1,076,000
-31.8%
44,040
-27.5%
0.00%
-42.9%
Q4 2018$1,577,000
+120.3%
60,782
+229.8%
0.01%
+133.3%
Q2 2018$716,00018,4320.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders